Spring, TX, United States of America

Yi Hu

This inventor holds 20 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent, primarily in Human Protein Research. Top assignees: Lexicon Genetics Corporation, Lexicon Pharmaceuticals, Inc., Kyorin Pharmaceutical Co., Ltd.. Active years: 2003-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Hu. Retrieved from https://idiyas.com/inventor/yi-hu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 15.0


 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • The Woodlands, TX (US) (2003 - 2004)
  • Woodlands, TX (US) (2005)
  • Spring, TX (US) (2003 - 2007)
  • San Diego, CA (US) (2011)

Company Filing History:


Years Active: 2003-2011

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Serine Hydrolase Inhibitors
FAM3C Variants
GABA Transporter Protein
Hydroxylases
Synaptotagmin
Kinase Proteins
Protease Inhibitor
Ion Channel Protein
7TM Proteins
Transferase Proteins
Transporter Proteins
20 patents (USPTO):Explore Patents

Title: The Innovations of Yi Hu: Pioneering Advances in Therapeutics

Introduction: Yi Hu, based in Spring, Texas, is an accomplished inventor known for his contributions to the fields of therapeutics and diagnostics. With a remarkable 19 granted patents, he has focused on advancements that have vast potential in pharmacogenomics and novel therapies for various medical conditions.

Latest Patents: Among Yi Hu's most recent patents are groundbreaking discoveries involving variants of the FAM3C gene. His work includes the disclosure of polynucleotide and polypeptide sequences that encode novel variant FAM3C proteins, which hold promise for therapeutic, diagnostic, and pharmacogenomic applications. Additionally, he has developed novel human polynucleotide and polypeptide sequences related to the human GABA transporter protein, further expanding the potential for innovative treatments and diagnostics.

Career Highlights: Throughout his career, Yi Hu has made significant contributions while working for celebrated organizations like Lexicon Genetics Corporation and Lexicon Pharmaceuticals, Inc. His research and innovations have played a crucial role in advancing medicine, particularly in the understanding and treatment of complex health issues.

Collaborations: In his journey, Yi Hu has collaborated with esteemed professionals, including Boris Nepomnichy and D Wade Walke. These partnerships have not only enriched his research but have fostered a collaborative environment that encourages shared knowledge and innovative thinking.

Conclusion: Yi Hu stands out as a leading inventor whose work continues to influence the scientific community. With numerous patents and innovative projects, he exemplifies the spirit of innovation that can lead to significant improvements in health care and therapeutic practices. His ongoing contributions are likely to pave the way for future breakthroughs in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…